Health in Guinea

1,161 indicators covering health for Guinea.

IndicatorLatest Year10-yr change Rank
Rate of disease burden from drug use disorders who 32.02 2021 up 6.0% 190th
Male female ratio suicides rates 1.97 2021 down 7.1% 171st
Number of people notified with new episode of TB in a given year 19,092 2021 up 64.5% 37th
Number of people diagnosed with new episode of pulmonary TB who are cl 3,492 2021 up 141.5% 41st
Number of people diagnosed with new episode of pulmonary TB who have e 4,702 2021 up 105.9% 28th
Antiretroviral therapy coverage for PMTCT 80.0% 2024 β€” 41st
Cases started on MDR-TB treatment 373 2024 up 200.8% 38th
Share healthy diet unaffordable 50 2024 up 12.6% 47th
Number of people diagnosed with new episode of pulmonary TB who are ba 10,560 2021 up 52.3% 36th
Raised fasting blood glucose (>=7.0 mmol/L) 6.4 2014 up 28.0% 154th
Mean fasting blood glucose (mmol/l) 4.64 2014 down 3.7% 182nd
Raised fasting blood glucose (>= 7.0 mmol/L) 4.7 2014 up 27.0% 170th
Reported number of people requiring interventions against NTDs 11.78 million 2024 up 33.3% 20th
Child deaths from streptococcus by disease 132 2015 down 10.2% 32nd
Births attended by skilled health personnel 55.3% 2018 up 20.2% 156th
Percentage of total deaths due to NCDs overall and percentage of total 58.53 2019 down 8.2% 11th
Number of new leprosy cases 199 2024 down 17.4% 36th
Pharmacists 0.15 2024 up 25.0% 150th
Inactivated first-dose polio vaccine (IPV1) immunization coverage amon 65.0% 2025 up 712.5% 184th
Number of new hivaids infections who 4,700 2024 down 50.5% 34th
Incidence of malaria 286.08 per 1,000 population at risk 2024 down 27.9% 11th
Reported number of children receiving antiretroviral therapy 7,429 2025 up 402.0% 15th
Concentrations of fine particulate matter 38.46 2023 up 10.3% 25th
Death rate road traffic injuries 29.7 2019 down 4.2% 26th
New or unknown treatment history cases: Pulmonary, bacteriologically c 10,627 2023 up 52.8% 40th
Cholera case fatality rate 0 2014 down 100.0% 37th
Medical doctors not further defined 1 2022 down 99.9% 150th
Life satisfaction vs life expectancy 60.74 2023 up 5.7% 229th
Tb patients tested positive for hiv 3,480 2021 up 108.4% 22nd
Number of children aged 6-59 months with anaemia 1,520 2019 up 14.3% 38th
Prevalence of anaemia in children aged 6-59 months 73.8% 2019 down 3.3% 4th
Number of deaths attributed to non-communicable diseases, by type of d 5,151 2019 up 23.7% 117th
Hepatitis B surface antigen (HBsAg) prevalence 2.8% 2024 up 27.3% 7th
Mean hemoglobin level of children aged 6-59 months 100 2019 up 2.0% 187th
Estimated number of MDR/RR-TB incident cases 1,100 2024 unchanged 33rd
Mortality caused by road traffic injury 29.7 per 100,000 population 2019 down 2.9% 26th
Mortality caused by road traffic injury, female 20.4 per 100,000 female population 2019 down 4.2% 13th
Mortality caused by road traffic injury, male 39.6 per 100,000 male population 2019 down 2.9% 35th
Ipv vaccine coverage 63 2024 up 687.5% 182nd
Tb patients living with hiv receiving art 3,392 2021 up 317.7% 19th
HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2024 up 33.3% 1st
Treatment success rate for patients treated for MDR-TB 76.0% 2022 down 5.0% 64th
New leprosy case detection rate per 1 000 000 population 13.49 2024 down 32.6% 39th
Treatment success rate: HIV-positive TB cases 88 2023 up 17.3% 28th
Prevalence of wasting, weight for height 6.4% 2022 down 36.0% 32nd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 0.0% 2025 β€” 167th
International Health Regulations core capacity scores, SPAR version, 2 60 2025 β€” 64th
Prevalence of underweight, weight for age 15.0% 2022 down 20.2% 31st
Leprosy registered prevalence rate per 1 000 000 population 14.23 2024 down 45.2% 40th
Leprosy - Number of new leprosy cases among children 13 2024 down 23.5% 32nd
Leprosy - Number of cases registered for treatment 210 2024 down 32.9% 37th
New leprosy child case detection rate (less than 15 years of age) per 2.15 2024 down 39.5% 35th
Children (0-14) living with HIV 11,000 2024 down 15.4% 17th
Ipv1 number unvaccinated 201,110 2023 down 44.8% 24th
Children living with hiv 11,000 2024 down 15.4% 17th
Contraceptive prevalence, any method 10.9% 2018 up 19.8% 115th
Children (ages 0-14) newly infected with HIV 1,100 2024 down 57.7% 19th
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 β€” 3rd
Number of children newly infected with hiv 1,100 2024 down 57.7% 19th
Share of children under fifteen years old with hiv 1,070 2024 down 59.4% 20th